nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC1—brainstem—multiple sclerosis	0.0427	0.0822	CbGeAlD
Dihydroxyaluminium—VDAC2—spinal cord—multiple sclerosis	0.0335	0.0645	CbGeAlD
Dihydroxyaluminium—VDAC3—medulla oblongata—multiple sclerosis	0.0313	0.0603	CbGeAlD
Dihydroxyaluminium—VDAC1—medulla oblongata—multiple sclerosis	0.0298	0.0573	CbGeAlD
Dihydroxyaluminium—VDAC3—midbrain—multiple sclerosis	0.0286	0.0551	CbGeAlD
Dihydroxyaluminium—VDAC2—nervous system—multiple sclerosis	0.0282	0.0544	CbGeAlD
Dihydroxyaluminium—VDAC3—spinal cord—multiple sclerosis	0.0279	0.0537	CbGeAlD
Dihydroxyaluminium—VDAC1—midbrain—multiple sclerosis	0.0272	0.0524	CbGeAlD
Dihydroxyaluminium—VDAC2—central nervous system—multiple sclerosis	0.0272	0.0523	CbGeAlD
Dihydroxyaluminium—VDAC2—cerebellum—multiple sclerosis	0.0266	0.0511	CbGeAlD
Dihydroxyaluminium—VDAC1—spinal cord—multiple sclerosis	0.0265	0.0511	CbGeAlD
Dihydroxyaluminium—VDAC3—nervous system—multiple sclerosis	0.0235	0.0453	CbGeAlD
Dihydroxyaluminium—VDAC3—central nervous system—multiple sclerosis	0.0226	0.0436	CbGeAlD
Dihydroxyaluminium—VDAC1—nervous system—multiple sclerosis	0.0224	0.0431	CbGeAlD
Dihydroxyaluminium—VDAC3—cerebellum—multiple sclerosis	0.0221	0.0426	CbGeAlD
Dihydroxyaluminium—VDAC2—brain—multiple sclerosis	0.0216	0.0415	CbGeAlD
Dihydroxyaluminium—VDAC1—central nervous system—multiple sclerosis	0.0215	0.0415	CbGeAlD
Dihydroxyaluminium—VDAC1—cerebellum—multiple sclerosis	0.021	0.0405	CbGeAlD
Dihydroxyaluminium—Blindness transient—Methotrexate—multiple sclerosis	0.0182	0.0413	CcSEcCtD
Dihydroxyaluminium—VDAC3—brain—multiple sclerosis	0.018	0.0346	CbGeAlD
Dihydroxyaluminium—VDAC1—brain—multiple sclerosis	0.0171	0.0329	CbGeAlD
Dihydroxyaluminium—Electrolyte imbalance—Methylprednisolone—multiple sclerosis	0.012	0.0273	CcSEcCtD
Dihydroxyaluminium—Extravasation—Cladribine—multiple sclerosis	0.0116	0.0264	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Dexamethasone—multiple sclerosis	0.0109	0.0248	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Betamethasone—multiple sclerosis	0.0109	0.0248	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Cladribine—multiple sclerosis	0.00855	0.0194	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.00824	0.207	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00811	0.204	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.00811	0.204	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.00792	0.199	CbGdCrCtD
Dihydroxyaluminium—Extravasation—Mitoxantrone—multiple sclerosis	0.00765	0.0173	CcSEcCtD
Dihydroxyaluminium—Back pain—Fingolimod—multiple sclerosis	0.00757	0.0172	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Fingolimod—multiple sclerosis	0.00738	0.0167	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.00734	0.185	CbGdCrCtD
Dihydroxyaluminium—Infection—Fingolimod—multiple sclerosis	0.00635	0.0144	CcSEcCtD
Dihydroxyaluminium—Hypotension—Fingolimod—multiple sclerosis	0.00597	0.0135	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Mitoxantrone—multiple sclerosis	0.00562	0.0128	CcSEcCtD
Dihydroxyaluminium—Extravasation—Dexamethasone—multiple sclerosis	0.00524	0.0119	CcSEcCtD
Dihydroxyaluminium—Extravasation—Betamethasone—multiple sclerosis	0.00524	0.0119	CcSEcCtD
Dihydroxyaluminium—Encephalopathy—Methotrexate—multiple sclerosis	0.00518	0.0117	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.00486	0.011	CcSEcCtD
Dihydroxyaluminium—Lung disorder—Methotrexate—multiple sclerosis	0.0047	0.0107	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Prednisolone—multiple sclerosis	0.00459	0.0104	CcSEcCtD
Dihydroxyaluminium—Chills—Cladribine—multiple sclerosis	0.00457	0.0104	CcSEcCtD
Dihydroxyaluminium—Dehydration—Mitoxantrone—multiple sclerosis	0.0045	0.0102	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Fingolimod—multiple sclerosis	0.00437	0.00992	CcSEcCtD
Dihydroxyaluminium—Back pain—Cladribine—multiple sclerosis	0.00429	0.00974	CcSEcCtD
Dihydroxyaluminium—Dizziness—Fingolimod—multiple sclerosis	0.00422	0.00958	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Triamcinolone—multiple sclerosis	0.00422	0.00957	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Methylprednisolone—multiple sclerosis	0.00421	0.00955	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Prednisolone—multiple sclerosis	0.00419	0.00951	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.00383	0.00869	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Betamethasone—multiple sclerosis	0.00383	0.00869	CcSEcCtD
Dihydroxyaluminium—Extravasation—Methotrexate—multiple sclerosis	0.00381	0.00864	CcSEcCtD
Dihydroxyaluminium—Chills—Azathioprine—multiple sclerosis	0.00372	0.00844	CcSEcCtD
Dihydroxyaluminium—Oedema—Cladribine—multiple sclerosis	0.00362	0.00821	CcSEcCtD
Dihydroxyaluminium—Infection—Cladribine—multiple sclerosis	0.0036	0.00816	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Cladribine—multiple sclerosis	0.00353	0.00802	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Dexamethasone—multiple sclerosis	0.0035	0.00794	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Betamethasone—multiple sclerosis	0.0035	0.00794	CcSEcCtD
Dihydroxyaluminium—Hypotension—Cladribine—multiple sclerosis	0.00338	0.00768	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Mitoxantrone—multiple sclerosis	0.00336	0.00762	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Prednisone—multiple sclerosis	0.00334	0.00757	CcSEcCtD
Dihydroxyaluminium—Pain—Cladribine—multiple sclerosis	0.0031	0.00702	CcSEcCtD
Dihydroxyaluminium—Coma—Methotrexate—multiple sclerosis	0.00304	0.00689	CcSEcCtD
Dihydroxyaluminium—Chills—Mitoxantrone—multiple sclerosis	0.00301	0.00682	CcSEcCtD
Dihydroxyaluminium—Infection—Azathioprine—multiple sclerosis	0.00293	0.00664	CcSEcCtD
Dihydroxyaluminium—Urticaria—Cladribine—multiple sclerosis	0.00288	0.00653	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Cladribine—multiple sclerosis	0.00286	0.00649	CcSEcCtD
Dihydroxyaluminium—Back pain—Mitoxantrone—multiple sclerosis	0.00282	0.0064	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Methotrexate—multiple sclerosis	0.00279	0.00632	CcSEcCtD
Dihydroxyaluminium—Hypotension—Azathioprine—multiple sclerosis	0.00275	0.00624	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Mitoxantrone—multiple sclerosis	0.00275	0.00624	CcSEcCtD
Dihydroxyaluminium—Polyuria—Methotrexate—multiple sclerosis	0.00275	0.00623	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Cladribine—multiple sclerosis	0.00267	0.00605	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Prednisolone—multiple sclerosis	0.00265	0.00601	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Methotrexate—multiple sclerosis	0.00255	0.00578	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Triamcinolone—multiple sclerosis	0.00253	0.00575	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Methylprednisolone—multiple sclerosis	0.00253	0.00574	CcSEcCtD
Dihydroxyaluminium—Convulsion—Mitoxantrone—multiple sclerosis	0.00253	0.00573	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Cladribine—multiple sclerosis	0.00248	0.00562	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Methylprednisolone—multiple sclerosis	0.00243	0.00551	CcSEcCtD
Dihydroxyaluminium—Dizziness—Cladribine—multiple sclerosis	0.00239	0.00543	CcSEcCtD
Dihydroxyaluminium—Oedema—Mitoxantrone—multiple sclerosis	0.00238	0.0054	CcSEcCtD
Dihydroxyaluminium—Infection—Mitoxantrone—multiple sclerosis	0.00236	0.00536	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Azathioprine—multiple sclerosis	0.00233	0.00528	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Mitoxantrone—multiple sclerosis	0.00232	0.00527	CcSEcCtD
Dihydroxyaluminium—Vomiting—Cladribine—multiple sclerosis	0.0023	0.00522	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Prednisolone—multiple sclerosis	0.00226	0.00512	CcSEcCtD
Dihydroxyaluminium—Hypotension—Mitoxantrone—multiple sclerosis	0.00222	0.00505	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Dexamethasone—multiple sclerosis	0.00221	0.00501	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Betamethasone—multiple sclerosis	0.00221	0.00501	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Azathioprine—multiple sclerosis	0.00217	0.00492	CcSEcCtD
Dihydroxyaluminium—Nausea—Cladribine—multiple sclerosis	0.00215	0.00488	CcSEcCtD
Dihydroxyaluminium—Vertigo—Prednisolone—multiple sclerosis	0.00215	0.00488	CcSEcCtD
Dihydroxyaluminium—Back pain—Triamcinolone—multiple sclerosis	0.00213	0.00483	CcSEcCtD
Dihydroxyaluminium—Convulsion—Prednisolone—multiple sclerosis	0.00207	0.0047	CcSEcCtD
Dihydroxyaluminium—Pain—Mitoxantrone—multiple sclerosis	0.00204	0.00462	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Azathioprine—multiple sclerosis	0.00201	0.00457	CcSEcCtD
Dihydroxyaluminium—Vertigo—Triamcinolone—multiple sclerosis	0.00198	0.00448	CcSEcCtD
Dihydroxyaluminium—Vertigo—Methylprednisolone—multiple sclerosis	0.00197	0.00447	CcSEcCtD
Dihydroxyaluminium—Oedema—Prednisolone—multiple sclerosis	0.00195	0.00443	CcSEcCtD
Dihydroxyaluminium—Dizziness—Azathioprine—multiple sclerosis	0.00195	0.00442	CcSEcCtD
Dihydroxyaluminium—Convulsion—Triamcinolone—multiple sclerosis	0.00191	0.00432	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Prednisolone—multiple sclerosis	0.00191	0.00432	CcSEcCtD
Dihydroxyaluminium—Convulsion—Methylprednisolone—multiple sclerosis	0.0019	0.00432	CcSEcCtD
Dihydroxyaluminium—Urticaria—Mitoxantrone—multiple sclerosis	0.00189	0.00429	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00188	0.00427	CcSEcCtD
Dihydroxyaluminium—Vomiting—Azathioprine—multiple sclerosis	0.00187	0.00425	CcSEcCtD
Dihydroxyaluminium—Oedema—Triamcinolone—multiple sclerosis	0.0018	0.00407	CcSEcCtD
Dihydroxyaluminium—Vertigo—Dexamethasone—multiple sclerosis	0.00179	0.00407	CcSEcCtD
Dihydroxyaluminium—Vertigo—Betamethasone—multiple sclerosis	0.00179	0.00407	CcSEcCtD
Dihydroxyaluminium—Infection—Triamcinolone—multiple sclerosis	0.00178	0.00405	CcSEcCtD
Dihydroxyaluminium—Infection—Methylprednisolone—multiple sclerosis	0.00178	0.00404	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00175	0.00398	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Triamcinolone—multiple sclerosis	0.00175	0.00398	CcSEcCtD
Dihydroxyaluminium—Nausea—Azathioprine—multiple sclerosis	0.00175	0.00397	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Methylprednisolone—multiple sclerosis	0.00175	0.00397	CcSEcCtD
Dihydroxyaluminium—Convulsion—Betamethasone—multiple sclerosis	0.00173	0.00392	CcSEcCtD
Dihydroxyaluminium—Convulsion—Dexamethasone—multiple sclerosis	0.00173	0.00392	CcSEcCtD
Dihydroxyaluminium—Hypotension—Methylprednisolone—multiple sclerosis	0.00167	0.0038	CcSEcCtD
Dihydroxyaluminium—Pain—Prednisolone—multiple sclerosis	0.00167	0.00379	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Prednisone—multiple sclerosis	0.00164	0.00372	CcSEcCtD
Dihydroxyaluminium—Oedema—Betamethasone—multiple sclerosis	0.00163	0.0037	CcSEcCtD
Dihydroxyaluminium—Oedema—Dexamethasone—multiple sclerosis	0.00163	0.0037	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00163	0.00369	CcSEcCtD
Dihydroxyaluminium—Infection—Dexamethasone—multiple sclerosis	0.00162	0.00367	CcSEcCtD
Dihydroxyaluminium—Infection—Betamethasone—multiple sclerosis	0.00162	0.00367	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Methotrexate—multiple sclerosis	0.00161	0.00365	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Betamethasone—multiple sclerosis	0.00159	0.00361	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Dexamethasone—multiple sclerosis	0.00159	0.00361	CcSEcCtD
Dihydroxyaluminium—Vertigo—Prednisone—multiple sclerosis	0.00156	0.00354	CcSEcCtD
Dihydroxyaluminium—Urticaria—Prednisolone—multiple sclerosis	0.00155	0.00352	CcSEcCtD
Dihydroxyaluminium—Pain—Triamcinolone—multiple sclerosis	0.00154	0.00348	CcSEcCtD
Dihydroxyaluminium—Hypotension—Dexamethasone—multiple sclerosis	0.00152	0.00345	CcSEcCtD
Dihydroxyaluminium—Hypotension—Betamethasone—multiple sclerosis	0.00152	0.00345	CcSEcCtD
Dihydroxyaluminium—Vomiting—Mitoxantrone—multiple sclerosis	0.00151	0.00343	CcSEcCtD
Dihydroxyaluminium—Convulsion—Prednisone—multiple sclerosis	0.00151	0.00342	CcSEcCtD
Dihydroxyaluminium—Chills—Methotrexate—multiple sclerosis	0.0015	0.0034	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Prednisolone—multiple sclerosis	0.00144	0.00326	CcSEcCtD
Dihydroxyaluminium—Urticaria—Triamcinolone—multiple sclerosis	0.00143	0.00324	CcSEcCtD
Dihydroxyaluminium—Urticaria—Methylprednisolone—multiple sclerosis	0.00142	0.00323	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Triamcinolone—multiple sclerosis	0.00142	0.00322	CcSEcCtD
Dihydroxyaluminium—Oedema—Prednisone—multiple sclerosis	0.00142	0.00322	CcSEcCtD
Dihydroxyaluminium—Nausea—Mitoxantrone—multiple sclerosis	0.00141	0.00321	CcSEcCtD
Dihydroxyaluminium—Infection—Prednisone—multiple sclerosis	0.00141	0.0032	CcSEcCtD
Dihydroxyaluminium—Back pain—Methotrexate—multiple sclerosis	0.00141	0.00319	CcSEcCtD
Dihydroxyaluminium—Pain—Betamethasone—multiple sclerosis	0.00139	0.00316	CcSEcCtD
Dihydroxyaluminium—Pain—Dexamethasone—multiple sclerosis	0.00139	0.00316	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Prednisone—multiple sclerosis	0.00139	0.00314	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Methotrexate—multiple sclerosis	0.00137	0.00311	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00132	0.003	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00132	0.00299	CcSEcCtD
Dihydroxyaluminium—Vertigo—Methotrexate—multiple sclerosis	0.00131	0.00296	CcSEcCtD
Dihydroxyaluminium—Urticaria—Betamethasone—multiple sclerosis	0.00129	0.00294	CcSEcCtD
Dihydroxyaluminium—Urticaria—Dexamethasone—multiple sclerosis	0.00129	0.00294	CcSEcCtD
Dihydroxyaluminium—Dizziness—Prednisolone—multiple sclerosis	0.00129	0.00293	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Betamethasone—multiple sclerosis	0.00129	0.00292	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Dexamethasone—multiple sclerosis	0.00129	0.00292	CcSEcCtD
Dihydroxyaluminium—Convulsion—Methotrexate—multiple sclerosis	0.00126	0.00286	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00123	0.00278	CcSEcCtD
Dihydroxyaluminium—Dizziness—Triamcinolone—multiple sclerosis	0.00119	0.00269	CcSEcCtD
Dihydroxyaluminium—Dizziness—Methylprednisolone—multiple sclerosis	0.00119	0.00269	CcSEcCtD
Dihydroxyaluminium—Infection—Methotrexate—multiple sclerosis	0.00118	0.00267	CcSEcCtD
Dihydroxyaluminium—Nausea—Prednisolone—multiple sclerosis	0.00116	0.00263	CcSEcCtD
Dihydroxyaluminium—Vomiting—Triamcinolone—multiple sclerosis	0.00114	0.00259	CcSEcCtD
Dihydroxyaluminium—Vomiting—Methylprednisolone—multiple sclerosis	0.00114	0.00258	CcSEcCtD
Dihydroxyaluminium—Urticaria—Prednisone—multiple sclerosis	0.00113	0.00256	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Prednisone—multiple sclerosis	0.00112	0.00254	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Betamethasone—multiple sclerosis	0.00112	0.00253	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Dexamethasone—multiple sclerosis	0.00112	0.00253	CcSEcCtD
Dihydroxyaluminium—Hypotension—Methotrexate—multiple sclerosis	0.00111	0.00251	CcSEcCtD
Dihydroxyaluminium—Dizziness—Betamethasone—multiple sclerosis	0.00108	0.00244	CcSEcCtD
Dihydroxyaluminium—Dizziness—Dexamethasone—multiple sclerosis	0.00108	0.00244	CcSEcCtD
Dihydroxyaluminium—Nausea—Triamcinolone—multiple sclerosis	0.00107	0.00242	CcSEcCtD
Dihydroxyaluminium—Nausea—Methylprednisolone—multiple sclerosis	0.00106	0.00241	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Prednisone—multiple sclerosis	0.00105	0.00237	CcSEcCtD
Dihydroxyaluminium—Vomiting—Betamethasone—multiple sclerosis	0.00104	0.00235	CcSEcCtD
Dihydroxyaluminium—Vomiting—Dexamethasone—multiple sclerosis	0.00104	0.00235	CcSEcCtD
Dihydroxyaluminium—Pain—Methotrexate—multiple sclerosis	0.00101	0.0023	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Prednisone—multiple sclerosis	0.000971	0.0022	CcSEcCtD
Dihydroxyaluminium—Nausea—Dexamethasone—multiple sclerosis	0.000968	0.0022	CcSEcCtD
Dihydroxyaluminium—Nausea—Betamethasone—multiple sclerosis	0.000968	0.0022	CcSEcCtD
Dihydroxyaluminium—Urticaria—Methotrexate—multiple sclerosis	0.000942	0.00214	CcSEcCtD
Dihydroxyaluminium—Dizziness—Prednisone—multiple sclerosis	0.000938	0.00213	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Methotrexate—multiple sclerosis	0.000938	0.00213	CcSEcCtD
Dihydroxyaluminium—Vomiting—Prednisone—multiple sclerosis	0.000902	0.00205	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Methotrexate—multiple sclerosis	0.000874	0.00198	CcSEcCtD
Dihydroxyaluminium—Nausea—Prednisone—multiple sclerosis	0.000843	0.00191	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Methotrexate—multiple sclerosis	0.000812	0.00184	CcSEcCtD
Dihydroxyaluminium—Dizziness—Methotrexate—multiple sclerosis	0.000784	0.00178	CcSEcCtD
Dihydroxyaluminium—Vomiting—Methotrexate—multiple sclerosis	0.000754	0.00171	CcSEcCtD
Dihydroxyaluminium—Nausea—Methotrexate—multiple sclerosis	0.000705	0.0016	CcSEcCtD
